Exhibit 99.3
WEBMD HEALTH CORP.
2007 FINANCIAL GUIDANCE SUMMARY
(in millions, except per share amounts)
| | | | | | | | | | | | | | | | | | | | |
| | | | | | Quarter Ended | | | Year Ended | |
| | Nine Months Ended | | | December 31, 2007 | | | December 31, 2007 | |
| | September 30, 2007 | | | Range | | | Range | |
Revenue | | $ | 238.6 | | | $ | 94.0 | | | $ | 98.0 | | | $ | 332.6 | | | $ | 336.6 | |
| | | | | | | | | | | | | | | | | | | | |
Earnings before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”) (a) | | | 51.8 | | | | 30.0 | | | | 32.5 | | | | 81.8 | | | | 84.3 | |
| | | | | | | | | | | | | | | | | | | | |
Adjusted EBITDA per diluted common share | | $ | 0.87 | | | $ | 0.50 | | | $ | 0.54 | | | $ | 1.36 | | | $ | 1.41 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Interest, taxes, depreciation, amortization and other non-cash items (b) | | | | | | | | | | | | | | | | | | | | |
Interest income | | | 8.5 | | | | 3.4 | | | | 3.5 | | | | 11.9 | | | | 12.0 | |
Depreciation and amortization | | | (20.0 | ) | | | (7.3 | ) | | | (7.1 | ) | | | (27.3 | ) | | | (27.1 | ) |
Non-cash advertising | | | (2.5 | ) | | | (3.2 | ) | | | (3.0 | ) | | | (5.7 | ) | | | (5.5 | ) |
Non-cash stock-based compensation | | | (15.6 | ) | | | (4.2 | ) | | | (4.1 | ) | | | (19.8 | ) | | | (19.7 | ) |
Income tax provision (c) | | | (4.7 | ) | | | (3.4 | ) | | | (3.8 | ) | | | (8.1 | ) | | | (8.5 | ) |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Net income | | $ | 17.6 | | | $ | 15.3 | | | $ | 18.0 | | | $ | 32.8 | | | $ | 35.5 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Net income per common share: | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Basic | | $ | 0.31 | | | $ | 0.27 | | | $ | 0.32 | | | $ | 0.57 | | | $ | 0.62 | |
| | | | | | | | | | | | | | | |
Diluted | | $ | 0.29 | | | $ | 0.26 | | | $ | 0.30 | | | $ | 0.55 | | | $ | 0.59 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Weighted-average shares outstanding used in computing net income per common share: | | | | | | | | | | | | | | | | | | | | |
Basic | | | 57.1 | | | | 57.1 | | | | 57.1 | | | | 57.1 | | | | 57.1 | |
| | | | | | | | | | | | | | | |
Diluted | | | 59.7 | | | | 60.0 | | | | 60.0 | | | | 60.0 | | | | 60.0 | |
| | | | | | | | | | | | | | | |
| | |
(a) | | See Annex A — Explanation of Non-GAAP Financial Measures |
|
(b) | | Reconciliation of Adjusted EBITDA to net income |
|
(c) | | Our guidance for Q4 2007 does not contemplate any benefit stemming from the reversal of valuation allowance against our deferred tax assets |
FINANCIAL GUIDANCE SUMMARY
2008 Financial Guidance
(in millions, except per share amounts)
| | | | | | | | |
| | Year Ended | |
| | December 31, 2008 | |
| | Range | |
Revenue | | $ | 420.0 | | | $ | 435.0 | |
| | | | | | | | |
Earnings before interest, taxes, depreciation, amortization and other non-cash items (“Adjusted EBITDA”) (a) | | | 120.0 | | | | 130.0 | |
| | | | | | | | |
Adjusted EBITDA per diluted common share | | $ | 1.94 | | | $ | 2.10 | |
| | | | | | |
| | | | | | | | |
Interest, taxes, depreciation, amortization and other non-cash items (b) | | | | | | | | |
Interest income | | | 14.0 | | | | 15.0 | |
Depreciation and amortization | | | (31.0 | ) | | | (29.0 | ) |
Non-cash advertising | | | (5.0 | ) | | | (5.0 | ) |
Non-cash stock-based compensation | | | (23.0 | ) | | | (22.0 | ) |
Income tax provision (c) | | | (31.0 | ) | | | (36.0 | ) |
| | | | | | |
| | | | | | | | |
Net income | | $ | 44.0 | | | $ | 53.0 | |
| | | | | | |
| | | | | | | | |
Net income per common share: | | | | | | | | |
Basic | | $ | 0.75 | | | $ | 0.90 | |
| | | | | | |
Diluted | | $ | 0.71 | | | $ | 0.85 | |
| | | | | | |
| | | | | | | | |
Weighted-average shares outstanding used in computing net income per common share: | | | | | | | | |
Basic | | | 59.0 | | | | 59.0 | |
Diluted | | | 62.0 | | | | 62.0 | |
| | |
(a) | | See Annex A — Explanation of Non-GAAP Financial Measures |
|
(b) | | Reconciliation of Adjusted EBITDA to net income |
|
(c) | | Our guidance for 2008 contemplates a non-cash federal tax provision, and does not contemplate any benefit stemming from the reversal of valuation allowance against our deferred tax assets |